Home/Case studies and news/Imidacloprid, thiamethoxam and clodinafop in the Republic of Moldova

Imidacloprid, thiamethoxam and clodinafop in the Republic of Moldova

02.07.2018
Registration of products based on imidacloprid, thiamethoxam and clodinafop in the Republic of Moldova has been suspended. Currently registered products will stay on the market until December 19, 2018. Future of these active substances will depend on the decision of the European Commission.

Back to the list


Up